MyAverix Finance
NS · Healthcare
Zenotech Laboratories Ltd (532039)
Pharmaceuticals & Biotechnology
Zenotech Laboratories Ltd (532039) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $2.68B, P/E ratio is -244.44, net margin is 10.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 532039
Zenotech Laboratories Ltd (532039) — FAQ
What is Zenotech Laboratories Ltd's market cap?
Zenotech Laboratories Ltd (532039) has a reported market cap of $2.68B (data as of 2026-07-10).
What is 532039's P/E ratio?
The price-to-earnings (P/E) ratio for Zenotech Laboratories Ltd (532039) is -244.44 (data as of 2026-07-10).
Does Zenotech Laboratories Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Zenotech Laboratories Ltd (532039). Check the MyAverix Finance app for the latest dividend data.
What sector is Zenotech Laboratories Ltd in?
Zenotech Laboratories Ltd (532039) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).
What exchange is 532039 listed on?
532039 is listed on NS.
What is Zenotech Laboratories Ltd's net margin?
Zenotech Laboratories Ltd (532039) reports a net margin of 10.0% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.